- ISRAEL21c - http://www.israel21c.org -
BiondVax to manufacture universal flu vaccine
Posted By Viva Sarah Press On October 30, 2012 @ 12:00 am In | 1 Comment
BiondVax Pharmaceuticals recently announced that it passed an intensive two-day QP GMP audit – giving it a green light to advance clinical development of its universal flu vaccine, M-001, in the EU. This demanding certification is a requirement for companies intending to manufacture a clinical grade product for human trials anywhere in Europe.
BiondVax, an innovative biopharmaceutical company developing a flu vaccine designed to provide multi-season and multi-strain protection against most human influenza virus strains, also announced that it will conduct collaborative studies with MonoSol Rx located in New Jersey, to investigate the activity of M-001 when formulated utilizing MonoSol’s technology for administration by mouth.
Advantages of an oral universal influenza vaccine include ease of delivery and increased compliance, due to the absence of needles, as well as ease of distribution.
Article printed from ISRAEL21c: http://www.israel21c.org
URL to article: http://www.israel21c.org/news/biondvax-to-manufacture-universal-flu-vaccine/
Copyright © 2012 Israel. All rights reserved.